StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Proceeds from Exercise of Options and Employee Share by Quarter

Proceeds from Exercise of Options and Employee Share Plans ($M)

Teva Pharmaceutical Industries Proceeds from Exercise of Options and Employee Share: $46M in Q3 2026. That is the highest of the 19 quarters on record here.

Latest, Q3 2026
46
Period ended Sep 30, 2026
Change on a year earlier
–
0 in Q3 2025
History
19 quarters
Since Q1 2016
Sources
11
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 10-Q (0000818686-26-000006) ↗

Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedProceeds from Exercise of Options and Employee Share Plans ($M)Year on yearSource
Q3 2026Sep 30, 202646–SEC Form 10-Q (0000818686-26-000006) ↗
Q2 2026Jun 30, 202613–SEC Form 10-Q (0001193125-26-323619) ↗
Q1 2026Mar 31, 202626+766.7%SEC Form 10-Q (0001193125-26-191513) ↗
Q4 2025Dec 31, 202544+266.7%SEC Form 10-K (0001193125-26-034532) ↗
Q3 2025Sep 30, 20250-100.0%SEC Form 10-Q (0000818686-26-000006) ↗
Q2 2025Jun 30, 20250–SEC Form 10-Q (0001193125-26-323619) ↗
Q1 2025Mar 31, 20253-50.0%SEC Form 10-Q (0001193125-26-191513) ↗
Q4 2024Dec 31, 202412–SEC Form 10-K (0001193125-26-034532) ↗
Q3 2024Sep 30, 20241–SEC Form 10-Q (0001193125-25-266895) ↗
Q2 2024Jun 30, 20240–SEC Form 10-Q (0001193125-25-169296) ↗
Q1 2024Mar 31, 20246–SEC Form 10-Q (0001193125-25-114889) ↗
Q4 2017Dec 31, 20170-100.0%SEC Form 10-K (0001193125-18-039076) ↗
Q3 2017Sep 30, 20170-100.0%6-K FY2017 (XBRL) ↗
Q2 2017Jun 30, 20170-100.0%6-K FY2017 (XBRL) ↗
Q1 2017Mar 31, 20170-100.0%6-K FY2017 (XBRL) ↗
Q4 2016Dec 31, 20161–SEC Form 10-K (0001193125-19-043564) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Proceeds from Exercise of Options and Employee Share ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/db-cf-opt-proceeds

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?